Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saag

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.
Lancet (London, England)|April 14, 2009
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Jonathan A C Sterne, Margaret May, et al.
The Journal of Clinical Investigation|December 9, 2025
Age modifies the association between sex and the plasma inflammatory proteome in treated HIVRebecca A Abelman, Samuel R Schnittman, Natalia Faraj Murad, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
Lancet (London, England)|April 20, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsPaul E Sax, David Wohl, Michael T Yin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2009
HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of PhysiciansChristine Lubinski, Judith Aberg, Arlene D Bardeguez, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Implementation Science Methods, Challenges, and Associated Solutions: Transportable Lessons Learned and Best Practices From the Second National Meeting for Research and Community Collaboration Toward Ending the HIV Epidemic in the United StatesRobin Gaines Lanzi, Allyson Varley, Corilyn Ott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.
Lancet (London, England)|April 14, 2009
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Jonathan A C Sterne, Margaret May, et al.
The Journal of Clinical Investigation|December 9, 2025
Age modifies the association between sex and the plasma inflammatory proteome in treated HIVRebecca A Abelman, Samuel R Schnittman, Natalia Faraj Murad, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
Lancet (London, England)|April 20, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsPaul E Sax, David Wohl, Michael T Yin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2009
HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of PhysiciansChristine Lubinski, Judith Aberg, Arlene D Bardeguez, et al.
Plos Medicine|September 10, 2014
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesAndrew Boulle, Michael Schomaker, Margaret T May, et al.
Annals of Internal Medicine|July 5, 2021
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational StudyJessie K Edwards, Stephen R Cole, Tiffany L Breger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Implementation Science Methods, Challenges, and Associated Solutions: Transportable Lessons Learned and Best Practices From the Second National Meeting for Research and Community Collaboration Toward Ending the HIV Epidemic in the United StatesRobin Gaines Lanzi, Allyson Varley, Corilyn Ott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
Pageof 9